About 40 million American women suffer from some type of sexual disorder – the most common being Hypoactive Sexual Desire Disorder, otherwise known as low sex drive.
A study appropriately called the Bloom Study, is testing a medication called LibiGel to see if it restores women’s sex drive. The study is looking for Seattle women who have lost their sex drive to be a part of the study (they’re looking for women in other cities, too).
You qualify if you’re at least 30 and you’ve either gone through menopause or had your ovaries removed. The study is looking at how safe and effective LibiGel is. The medication is applied daily to the skin on a woman’s upper arm. The study is sponsored by BioSante Pharmaceuticals.
“Currently, there are no medications approved by the FDA for the treatment of low sexual desire,” said Dr. James Simon, a LibiGel study investigator and clinical professor of obstetrics and gynecology at George Washington University in Washington, D.C. “We know there is a tremendous medical need to address women suffering with low sexual desire.”